Tau protein and apolipoprotein E in CSF diagnostics of Alzheimer’s disease: impact on non Alzheimer’s dementia?
Tau protein and apolipoprotein E are suggested to be biochemically related to neurofibrillary tangles and senile plaques in Alzheimer’s disease (AD) brains. They can be detected as immunoreactive material (total tau immunoreactivity [TTIR] and apolipoprotein E-immunoreactivity [ApoEIR]) in the cerebrospinal fluid (CSF).
TTIR and ApoE-IR have been measured in ex vivo lumbar and post mortem ventricular CSF in AD, other neurological diseases without cognitive impairment, elderly depressive patients, and young and elderly controls.
In lumbar CSF, there was a highly significant increase of TTIR and a minor, insignificant decrease of ApoE-IR in CSF of AD patients. The latter result was also found in ventricular CSF, whereas TTIR showed no significant difference between groups in the rostral CSF compartment.
As depressive periods in the elderly may mimick a dementing process, these findings contribute to the differential diagnosis of these disorders by showing a different neurobiochemical CSF profile. Work in progress will include a variety of non-Alzheimer’s dementias and possibly will further increase the value of CSF investigation in neurodegenerative disorders.
KeywordsMini Mental Status Examination Neurofibrillary Tangle Mini Mental Status Examination Score ApoE Level Paired Helical Filament
Unable to display preview. Download preview PDF.
- Blennow K, Hesse C, Fredman P (1994) Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer’s disease. NeuroReport 5: 2534–2536Google Scholar
- Carlsson J, Armstrong VW, Reiber H, Felgenhauer K, Seidel D (1991) Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chim Acta 196: 167–176Google Scholar
- Jellinger K, Bancher C, Fischer P, Lassmann H (1992) Quantitative histopathologic validation of senile dementia of the Alzheimer type. Eur J Gerontol 3: 146–156Google Scholar
- Mercken M, Vandermeeren M, Lübcke U, Six J, Boons J, Vanmechelen E, Van de Voorde A, Gheuens J (1992) Affinity purification of human tau proteins and the construction of a sensitive sandwich enzyme-linked immunosorbent assay for human tau detection. J Neurochem 58: 548–553PubMedCrossRefGoogle Scholar
- Namba Y, Tomanaga M, Kawasaki H, Otomo E, Ikeda K (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541: 163–166Google Scholar
- Poirier J (1994) Apolipoprotein E in animals models of CNS injury and in Alzheimer’s disease. Trends Neurosci 17: 525–530Google Scholar
- Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high avidity binding to 13-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977–1981PubMedCrossRefGoogle Scholar
- Van de Voorde A, Vanmechelen E, Vandermeeren M, Dessaint F, Beckman W, Cras P (1995) Detection of tau in cerebrospinal fluid. In: Iqbal K, Mortimer JA, Winblad W, Wisniewski HM (eds) Research advances in Alzheimer’s disease and related disorders. Wiley, Chichester, pp 189–195Google Scholar